Common Stock, Shares, Outstanding of Emmaus Life Sciences, Inc. from 30 Sep 2010 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Emmaus Life Sciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Sep 2010 to 30 Sep 2025.
  • Emmaus Life Sciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 63,865,571, unchanged year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Emmaus Life Sciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 63,865,571 0 0% 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q2 2025 63,865,571 0 0% 30 Jun 2025 10-Q 14 Aug 2025 2025 Q2
Q1 2025 63,865,571 +2,019,608 +3.3% 31 Mar 2025 10-Q 15 May 2025 2025 Q1
Q4 2024 63,865,571 +2,019,608 +3.3% 31 Dec 2024 10-Q 14 Nov 2025 2025 Q3
Q3 2024 63,865,571 +10,228,017 +19% 30 Sep 2024 10-Q 19 Nov 2024 2024 Q3
Q2 2024 63,865,571 +10,228,017 +19% 30 Jun 2024 10-Q 10 Sep 2024 2024 Q2
Q1 2024 61,845,963 +10,911,111 +21% 31 Mar 2024 10-Q 10 Sep 2024 2024 Q1
Q4 2023 61,845,963 +12,262,462 +25% 31 Dec 2023 10-K 14 Apr 2025 2024 FY
Q3 2023 53,637,554 +4,079,053 +8.2% 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q2 2023 53,637,554 +4,079,053 +8.2% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 50,934,852 +1,622,988 +3.3% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 49,583,501 +271,637 +0.55% 31 Dec 2022 10-K 03 Jul 2024 2023 FY
Q3 2022 49,558,501 +246,637 +0.5% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 49,558,501 +246,637 +0.5% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 49,311,864 0 0% 31 Mar 2022 10-Q 13 May 2022 2022 Q1
Q4 2021 49,311,864 +324,675 +0.66% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 49,311,864 +324,675 +0.66% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 49,311,864 +324,675 +0.66% 30 Jun 2021 10-Q 01 Sep 2021 2021 Q2
Q1 2021 49,311,864 +324,675 +0.66% 31 Mar 2021 10-Q 13 May 2022 2022 Q1
Q4 2020 48,987,189 +515,743 +1.1% 31 Dec 2020 10-K 31 Mar 2022 2021 FY
Q3 2020 48,987,189 +1,315,743 +2.8% 30 Sep 2020 10-Q 26 Aug 2021 2020 Q3
Q2 2020 48,987,189 +11,106,978 +29% 30 Jun 2020 10-Q 26 Aug 2021 2020 Q2
Q1 2020 48,987,189 +11,236,765 +30% 31 Mar 2020 10-Q 26 Aug 2021 2020 Q1
Q4 2019 48,471,446 +11,130,053 +30% 31 Dec 2019 10-Q 26 Aug 2021 2020 Q2
Q3 2019 47,671,446 +40,264,192 +544% 30 Sep 2019 10-K 25 Jan 2021 2019 FY
Q2 2019 37,880,211 +31,618,614 +505% 30 Jun 2019 10-Q 26 Aug 2021 2020 Q2
Q1 2019 37,750,424 +33,386,113 +765% 31 Mar 2019 10-Q 26 Aug 2021 2020 Q1
Q4 2018 37,341,393 +32,980,832 +756% 31 Dec 2018 10-K 25 Jan 2021 2019 FY
Q3 2018 7,407,254 +3,107,943 +72% 30 Sep 2018 10-Q 14 Aug 2019 2019 Q3
Q2 2018 6,261,597 +3,722,536 +147% 30 Jun 2018 10-Q 10 Aug 2018 2018 Q3
Q1 2018 4,364,311 +1,836,250 +73% 31 Mar 2018 10-Q 14 May 2018 2018 Q2
Q4 2017 4,360,561 +2,099,500 +93% 31 Dec 2017 10-Q 20 Feb 2018 2018 Q1
Q3 2017 4,299,311 +2,358,250 +121% 30 Sep 2017 10-K 11 Dec 2018 2018 FY
Q2 2017 2,539,061 -104,928,348 -98% 30 Jun 2017 10-Q 14 Aug 2017 2017 Q3
Q1 2017 2,528,061 -100,189,348 -98% 31 Mar 2017 10-Q 15 May 2017 2017 Q2
Q4 2016 2,261,061 -100,156,348 -98% 31 Dec 2016 10-Q/A 30 Mar 2017 2017 Q1
Q3 2016 1,941,061 +1,428,656 +279% 30 Sep 2016 10-K 29 Dec 2017 2017 FY
Q2 2016 107,467,409 +5,800,000 +5.7% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q3
Q1 2016 102,717,409 +1,050,000 +1% 31 Mar 2016 10-Q 16 May 2016 2016 Q2
Q4 2015 102,417,409 +750,000 +0.74% 31 Dec 2015 10-Q 17 Feb 2016 2016 Q1
Q3 2015 512,405 -101,155,004 -99% 30 Sep 2015 10-K 22 Dec 2016 2016 FY
Q2 2015 101,667,409 +1,040,000 +1% 30 Jun 2015 10-Q 14 Aug 2015 2015 Q3
Q1 2015 101,667,409 +1,120,179 +1.1% 31 Mar 2015 10-Q 18 May 2015 2015 Q2
Q4 2014 101,667,409 +5,604,467 +5.8% 31 Dec 2014 10-Q 13 Feb 2015 2015 Q1
Q3 2014 101,667,409 +8,950,847 +9.7% 30 Sep 2014 10-K 05 Jan 2016 2015 FY
Q2 2014 100,627,409 +50,783,699 +102% 30 Jun 2014 10-Q 14 Aug 2014 2014 Q3
Q1 2014 100,547,230 +70,729,762 +237% 31 Mar 2014 10-Q 15 May 2014 2014 Q2
Q4 2013 96,062,942 +93,982,977 +4518% 31 Dec 2013 10-Q 13 Feb 2014 2014 Q1
Q3 2013 92,716,562 +90,802,387 +4744% 30 Sep 2013 10-K 29 Dec 2014 2014 FY
Q2 2013 49,843,710 +47,969,535 +2560% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q3
Q1 2013 29,817,468 +27,943,293 +1491% 31 Mar 2013 10-Q 15 May 2013 2013 Q2
Q4 2012 2,079,965 -54,138,466 -96% 31 Dec 2012 10-Q/A 22 Feb 2013 2013 Q1
Q3 2012 1,914,175 +42,823 +2.3% 30 Sep 2012 10-K 23 Dec 2013 2013 FY
Q2 2012 1,874,175 -54,243,425 -97% 30 Jun 2012 10-Q/A 11 Sep 2012 2012 Q3
Q1 2012 1,874,175 31 Mar 2012 10-Q 15 May 2012 2012 Q2
Q4 2011 56,218,431 31 Dec 2011 10-Q 14 Feb 2012 2012 Q1
Q3 2011 1,871,352 -54,152,569 -97% 30 Sep 2011 10-K 15 Jan 2013 2012 FY
Q2 2011 56,117,600 30 Jun 2011 10-Q/A 09 Sep 2011 2011 Q3
Q3 2010 56,023,921 30 Sep 2010 10-K 22 Dec 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.